The year of 2020 has seen fast start-up timelines for clinical trials and adaptations to trial designs to adjust to COVID-19. Regulatory authorities formulated more guidelines around decentralized trials, and while some sponsors capitalized on previous experiences, many used a decentralized model for the first time. If sponsors have learned anything this year, it’s that direct-to-patient logistics has become a vital and viable solution for clinical trial sponsors.
Advancing into 2021, it’s all about building more inclusive and patient-focused trials. So how can sponsors better incorporate the patient voice into their trials? How do they see decentralized trial capabilities expanding in the coming months to support this new era? Join this free webinar to learn more.
Scott Dixon, Senior Vice President, Product Strategy, Suvoda
Scott Dixon has spent his entire career in the life sciences technology industry, holding senior leadership positions at companies including ERT, Oracle, Phase Forward, WebMD, and Parexel. As Senior Vice President of Product Strategy, Dixon oversees Suvoda’s product roadmap and vision while leading the teams responsible for development, management and marketing. Prior to this role, Dixon acted as VP of Strategic Partnerships at Suvoda, developing strategic initiatives for sales and business development, as well as establishing and enhancing Suvoda’s business partnership relationships. Dixon is a versatile leader with a proven track record in consistently delivering new product and market strategies for star-tups and Fortune 100 companies in the life sciences and healthcare software application industry.Message Presenter
John Ristuccia, Senior Vice President, Global Client Services, Suvoda
John Ristuccia has over 20 years of experience in the software industry, holding a variety of leadership positions in global operations, marketing and professional services. As Senior Vice President, Global Client Services at Suvoda, Ristuccia provides comprehensive oversight, strategic direction and guidance for global services delivery teams. Prior to Suvoda, Ristuccia oversaw services and operational planning for global accounts at Optymyze, where he was a key member in driving overall corporate strategy and executing business development initiatives for cross-functional business units including services, product, finance, marketing and sales. Ristuccia has also consulted with Fortune 2000 companies to structure and negotiate proposals for solutions bringing strategic outcomes that drove sales effectiveness and improved sales operations. Ristuccia holds a Bachelor of Science in Biotechnology from the University of Delaware.Message Presenter
Who Should Attend?
Executives, Vice Presidents, Directors, Managers from Pharmaceutical, Biotechnology, and CRO companies involved in:
- Clinical Operations
- Clinical Supply Management
- Study Management
- Procurement and Outsourcing
- IRT (Interactive Response Technology)
What You Will Learn
In this presentation, attendees will learn:
- How partnerships with best-in-class technology companies will safeguard against the year’s coming challenges
- Why patient-centricity will no longer be considered to be just an industry buzzword
- How direct-to-patient logistics helps enable other complex trial designs and increases inclusivity
- How eClinical solutions such as IRT, eConsent, and eCOA can create lasting impacts in productivity and patient engagement
Suvoda solves complex patient randomization and clinical supply chain challenges, so that customers have the peace of mind to focus on their patients. Suvoda IRT with Trial Intelligence (IRT+TI) offers speed, agility, and insight to handle the most complex clinical trials with ease, offering a comprehensive solution to optimize and manage the supply chain across the breadth of the clinical trial continuum.